{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:20:27Z","timestamp":1787656827410,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jmoldx.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:31:51Z","timestamp":1781911911000},"page":"702-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-Based PCR Assay"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-458X","authenticated-orcid":false,"given":"Gloria H.","family":"Sura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Arjuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-5477","authenticated-orcid":false,"given":"Mohamed H.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzifa","family":"Duose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lize","family":"Bollen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bieke","family":"Van Dorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.A.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Caffes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-0645","authenticated-orcid":false,"given":"Ying-Chun","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2026.06.002_bib1","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41598-023-31055-3","article-title":"Systematic review of NTRK 1\/2\/3 fusion prevalence pan-cancer and across solid tumours","volume":"13","author":"O'Haire","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib2","article-title":"A review of NTRK fusions in cancer","volume":"79","author":"Manea","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/1078-0432.CCR-20-2771","article-title":"FDA approval summary: entrectinib for the treatment of NTRK gene fusion solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41416-024-02760-1","article-title":"Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents","volume":"131","author":"Roa","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-19-0372","article-title":"Detection of NTRK fusions: merits and limitations of current diagnostic platforms","volume":"79","author":"Solomon","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cncy.22930","article-title":"Same-day molecular testing for targetable mutations in solid tumor cytopathology-the next frontier of the rapid on-site evaluation","volume":"133","author":"Iorgulescu","year":"2025","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jmoldx.2022.03.014","article-title":"NTRK gene fusion detection in a pan-cancer setting using the Idylla GeneFusion assay","volume":"24","author":"Sorber","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib9","article-title":"Clinical utility validation of an automated ultrarapid gene fusion assay for NSCLC","volume":"3","author":"Buglioni","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jmoldx.2016.09.011","article-title":"A targeted high-throughput next-generation sequencing panel for clinical screening of mutations, gene amplifications, and fusions in solid tumors","volume":"19","author":"Luthra","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jmoldx.2025.01.002","article-title":"Clinical validation of the TruSight Oncology 500 assay for the detection and reporting of pan-cancer biomarkers","volume":"27","author":"Al-Kateb","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jmoldx.2024.10.004","article-title":"SARCP, a clinical next-generation sequencing assay for the detection of gene fusions in sarcomas: a description of the first 652 cases","volume":"27","author":"Atiq","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814203","article-title":"Cost-efficient detection of NTRK1\/2\/3 gene fusions: single-center analysis of 8075 tumor samples","volume":"24","author":"Romanko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41379-021-00913-8","article-title":"NTRK insights: best practices for pathologists","volume":"35","author":"Hechtman","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchio","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/dc.24378","article-title":"Rapid on-site molecular evaluation in thyroid cytopathology: a same-day cytological and molecular diagnosis","volume":"48","author":"De Luca","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cyt.13406","volume":"35","author":"Haragan","year":"2024","journal-title":"Cytopathology"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jmoldx.2022.05.004","article-title":"Multicenter evaluation of the Idylla GeneFusion in non-small-cell lung cancer","volume":"24","author":"Depoilly","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.06.002_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00428-024-03778-9","article-title":"Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC","volume":"484","author":"Melchior","year":"2024","journal-title":"Virchows Arch"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:40Z","timestamp":1787654140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157826001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525157826001054"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.06.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-Based PCR Assay","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the Association for Molecular Pathology and American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}